Nobody warned you your skin would change like this. It is not in your head.
Nobody warned you your skin would change like this. It is not in your head.
Perimenopause and Menopause Skin Treatment in South Yarra
Nobody warned you your skin would change like this. It is not in your head.
Most women arrive at this stage having been told about hot flushes and very little else.
Then the skin changes. It becomes dry in a way it never was, or breaks out at forty-seven after thirty years of clarity. It stings when it never used to. Pigment surfaces. The jawline softens. Products that worked for a decade stop working, and several of them now sting.
And when you mention it, the response is usually some version of well, that is just age.
It is not just age. Something specific and measurable is happening, on a timeline that is unusually compressed, and the reason so few people can explain it to you is that skin has historically been left out of the menopause conversation almost entirely. Even now, despite skin being among the organs most affected, there are no approved therapies specifically for menopausal skin change.
That does not mean nothing can be done. It means you have to know what you are dealing with.
This is the part that reframes everything, so it is worth understanding properly.
Oestrogen receptors, both alpha and beta types, are expressed throughout the skin. In the keratinocytes of the epidermis, in the fibroblasts of the dermis, and in the hair follicles. Your skin is a hormone-responsive organ, and it always has been.
Across your reproductive life, oestrogen has been doing at least six jobs there.
Building collagen. It stimulates collagen synthesis directly, and it particularly supports type III collagen.
Protecting the collagen you already have. It limits the activity of the enzymes that degrade collagen, so it is working on both sides of the equation at once.
Maintaining elasticity. It supports the morphology and synthesis of elastic fibres.
Holding water. It increases the levels of glycosaminoglycans and hyaluronic acid in the dermis, and it increases the water-holding capacity of the stratum corneum itself.
Supporting the barrier and sebum. Both directly, through barrier function, and indirectly by maintaining sebaceous output.
Acting as an antioxidant. Oestrogen's chemical structure allows it to directly attenuate reactive oxygen species, which are a primary driver of skin ageing.
Read that list again, then consider what happens when the supply falls away over a few years.
Every single one of those functions declines at once. That is why this does not feel like gradual ageing. It feels like something changed, because something did.
Perimenopause is the transition. Ovarian function becomes erratic rather than simply declining, and oestrogen levels fluctuate unpredictably, sometimes to levels higher than in your thirties before falling again. It commonly begins in the mid-forties but can start considerably earlier, and it typically lasts four to eight years.
The instability is the defining feature and it is why perimenopausal skin is so unpredictable. You are not on a smooth downward slope. You are on a rollercoaster.
Menopause is a single point in time, defined retrospectively as twelve consecutive months without a period. Everything after it is postmenopause.
Current guidance, including the NICE guideline on menopause identification and management, is that diagnosis in women over forty-five is clinical, based on symptoms, and does not require blood tests. Fluctuating hormone levels make single measurements unreliable, which is one reason so many women are told their bloods are normal while feeling anything but.
If you are under forty-five and experiencing these changes, that does warrant investigation with your GP.
Research published in Obstetrics and Gynecology in 1987 examined skin collagen content in postmenopausal women and found that approximately thirty percent of skin collagen is lost in the first five years after menopause, with an average decline of around two percent per year across the subsequent two decades.
Thirty percent. In five years.
Estimates of early postmenopausal collagen loss in more recent literature sit in a similar range, generally cited at around one to two percent per year in the early postmenopausal period.
For context, ordinary chronological collagen decline from the mid-twenties runs at roughly one percent per year. So the years immediately around menopause represent a compression of what would otherwise be decades of change.
This is not offered to alarm you. It is offered because women are routinely told they are imagining a change that is one of the more dramatic things documented in skin physiology, and because knowing the timeline tells you when intervention is worth the most.
Sebum production falls. Lipid synthesis declines. The stratum corneum loses water-holding capacity. Transepidermal water loss increases.
The result is skin that feels tight, looks dull, and no longer tolerates what it used to. This is frequently the first thing women notice and the thing most often dismissed.
Critically, it is also why your existing routine stopped working. A cleanser that was fine at thirty-eight can be actively stripping at forty-eight, on skin with considerably less lipid to spare.
Collagen and elastin decline together. The dermis thins. Skin becomes less able to spring back.
The jawline and the neck usually show it first, along with the area around the mouth and the crepey quality that appears under the eyes and across the décolletage.
As oestrogen falls, the ratio between oestrogen and androgens shifts. Androgens have not necessarily risen, but their relative influence has, and sebaceous glands respond to that ratio.
The result can be acne appearing for the first time in someone's forties or fifties, typically along the jawline and chin. It is deeply demoralising, it arrives alongside dryness rather than instead of it, and it cannot be treated the way teenage acne is treated.
Perimenopause is a classic time for melasma to appear for the first time or to reactivate after years of quiet, driven by the erratic oestrogen fluctuation rather than by decline.
At the same time, decades of accumulated sun damage begins surfacing against thinner skin.
There is also a factor almost nobody connects. Heat stimulates pigment production independently of UV. Vasomotor symptoms mean repeated episodes of heat and flushing throughout the day, which is a genuine pigmentary consideration and worth raising with your doctor as part of the broader picture rather than treating as separate from your skin.
A thinner, drier, more permeable barrier is a more reactive one. Products sting. Treatments that were comfortable become uncomfortable. Skin that has never been sensitive becomes so.
This is one of the more distressing changes because it narrows your options at exactly the point you need more of them.
Vasomotor symptoms and vascular reactivity often increase, and rosacea can appear or worsen during this period. Established rosacea frequently becomes harder to manage.
The same androgen ratio shift that drives acne can produce coarser hair on the chin and upper lip, while scalp hair thins. It is a cruel combination and it is extremely common.
This one matters clinically. Oestrogen enhances fibroblast migration and supports every phase of wound healing, and its decline is associated with delayed healing.
Practically, that means recovery from peels, needling and resurfacing takes longer than it did, and treatment intervals need extending accordingly.
Here is the tension that defines everything we do on this page.
Your skin needs more than it used to, and it tolerates less than it used to. Those two things are true at the same time and they pull in opposite directions.
The instinct is to treat harder, because the change feels urgent and the previous routine has stopped working. That instinct is almost always wrong. Aggressive correction on a thinner, drier, more reactive, slower-healing skin produces inflammation, and inflammation degrades collagen. It is entirely possible to spend a great deal of money accelerating the thing you are trying to slow.
The approach that works is gentler, more layered, more patient, and sequenced with the barrier first. That is less exciting than what you will be sold elsewhere, and it is what produces results.
We should address this because it comes up in almost every consultation.
Whether hormone therapy is appropriate for you is a medical decision, made with your GP or a menopause specialist, weighing your full history and a range of considerations of which skin is only one and not the most important.
We are a medical-dermal clinic, not a prescribing practice for this, and we will not offer you a view on it. What we will do is note that oestrogen has well-documented effects on skin physiology, that this is one of many factors your doctor may consider, and that if you are already on hormone therapy it is genuinely useful for us to know.
If you want to explore it, the Australasian Menopause Society maintains a directory of practitioners with particular expertise in this area, and your GP is the right first conversation.
One practical note for us. Hormone therapy can occasionally reactivate melasma in women who have had it before. If your pigment changed after starting, mention it. There are usually options and it is a conversation for your prescriber rather than a reason to stop something helping you elsewhere.
We are a medical-dermal clinic. Caitlin is a Registered Nurse with ten years in cosmetic medicine, Belinda is our Senior Dermal Clinician with around ten years of industry experience, and the whole team works to a shared philosophy: assess first, treat conservatively, sequence with intent, and never do more to the skin than it can handle.
For this stage of life that philosophy is not a preference. It is the clinical requirement.
Our approach has four parts, in this order. Rebuild the barrier. Reduce inflammation. Stimulate collagen. Correct the pigment and vascular damage that has surfaced.
The order is not negotiable, and the first two take longer than people want them to.
Your routine needs rebuilding rather than supplementing, and that is the most common thing we correct at this stage.
What follows is not a list for you to shop from. The reason matters here more than usual, because menopausal skin is where the wrong product does not simply fail. It provokes.
We look at your skin in person and in real time. A Wood's lamp separates epidermal pigment from dermal and reveals sun damage that has not yet surfaced. A dermatoscope examines vessels, texture and pigment pattern under magnification.
Most usefully, we work out which of the changes above are actually present in your skin, because women at this stage typically have four or five happening simultaneously and they need addressing in a particular order.
Our Dermal Clinicians hold a Bachelor of Dermal Science and bring over a decade of hands-on work with skin.
iS Clinical Cream Cleanser. Non-foaming, non-stripping. For many women, changing this single product produces more improvement in a fortnight than everything else they were doing. If your skin feels tight afterwards, the cleanser is working against you.
iS Clinical Reparative Moisture Emulsion for lighter needs, carrying hyaluronic acid, superoxide dismutase and copper tripeptide-1.
iS Clinical Youth Intensive Crème where skin has become genuinely dry and needs substance. Built around a bioidentical copper tripeptide growth factor with peptides and antioxidant support, and our most-recommended moisturiser at this stage.
iS Clinical SHEALD Recovery Balm for the driest presentations and through a Melbourne winter.
Dermaceutic Hyal Ceutic for intensive hydration, and K Ceutic, which repairs and protects at SPF 50 in one step and keeps a routine short.
Retinoids remain the most evidence-supported topical for collagen and turnover. Research published in the New England Journal of Medicine demonstrated restoration of collagen formation in photodamaged skin with topical retinoic acid.
We work with the iS Clinical Retinol+ Emulsions in graduated strengths of 0.3, 0.6 and 1.0, with the retinol encapsulated in bio-identical lipids for gradual release. That encapsulation matters enormously here, because a strong retinoid introduced quickly to menopausal skin is one of the fastest ways to compromise a barrier that is already struggling.
We start at 0.3, every third night. Many women stay there permanently and get excellent results.
Vitamin C. Antioxidant protection plus an essential cofactor role in collagen synthesis, which matters when synthesis is exactly what has declined. iS Clinical Super Serum Advance+ pairs fifteen percent L-ascorbic acid with a bioidentical copper tripeptide growth factor, plus arbutin and kojic acid for the pigment that so often accompanies this stage.
Sunscreen, daily. UV degrades collagen through the same enzymes that are already more active. Protecting is cheaper than rebuilding.
Peptides and growth factors as supporting players, with copper peptides having the better evidence of the group.
The periorbital skin and the neck show this stage earlier and more obviously than the face, and they are almost always skipped.
iS Clinical Youth Eye Complex is our most requested, combining hyaluronic acid at fifteen percent, acetyl octapeptide-3, a bioidentical copper tripeptide growth factor and vitamins A, B5, C and E.
Whatever you use on your face should continue to your neck and décolletage, at the same frequency.
Where most people at this stage begin, and where several stay for the first six weeks.
Barrier Repair Facial is focused entirely on soothing and replenishing, with no acids and no exfoliation. LED uses red and near-infrared light to reduce inflammation and support repair, with no downtime and no capacity to provoke.
Unglamorous, and the foundation everything else is built on.
Our leveled peel program, drawing on professional ranges from PCA Skin, Dermaceutic, Toskani, Société, Cosmedix and Mesoestetic.
Level One, for enzyme and gentle lactic work. Lactic acid deserves specific mention at this stage, because it is an alpha hydroxy acid with genuine humectant properties, exfoliating while drawing water in. On drier, thinner skin that is a real advantage.
Level Two, for pigment and epidermal texture.
Level Three, our medium-depth TCA level, for established photodamage and textural change. Used more selectively at this stage and always with proper preparation, because healing is slower and the margin for error narrower.
Our primary collagen-building treatment, and the most directly relevant thing we offer to the central problem of this page.
Controlled micro-channels trigger a wound-healing cascade, and fibroblasts lay down new collagen and elastin over the following months. The same channels allow targeted actives to reach useful depth.
Level One pairs needling with an LED or peel and a hyaluronic acid glide. Level Two adds a medical booster infusion.
For this stage we most often reach for polynucleotides including PDRN for tissue repair and fibroblast stimulation, PLLA as a biostimulator building collagen gradually over months, peptides and growth factors, and hyaluronic acid for the dermal hydration that has declined. Byryzn Opuluxe V, combining PLLA, trout DNA PDRN, hyaluronic acid, glutathione, sphingomonas ferment extract, adenosine and amino acid and vitamin complexes, suits skin needing several things simultaneously, which describes most skin at this stage.
We space treatments further apart than we would in a younger patient, because healing is slower. That is not caution for its own sake.
The Lumenis M22 Stella with XPL, for the pigment and vascular damage that surfaces at this stage. Solar lentigines, diffuse redness and visible vessels all respond.
We assess carefully where melasma is part of the picture, because light-based treatment can worsen it.
Fractional CO2 resurfacing is joining the clinic, and for this stage it addresses what neither peels nor needling quite reach: established photodamage, texture, fine lines and overall surface quality.
The CoolPeel protocol delivers energy in very short pulses so the surface is resurfaced without heat accumulating in surrounding tissue, which narrows the historic trade-off between results and downtime considerably.
Preparation still comes first, and healing timelines at this stage are longer. We will raise it at consultation if it suits you.
This is one of the stages where the internal work has the most legitimate claim, because so much of what is happening is systemic rather than cutaneous.
Alida works on inflammation, sleep, stress load, gut function and nutritional status. Several of these are directly relevant to skin at this stage. Disrupted sleep, which is close to universal in perimenopause, measurably impairs collagen production and raises cortisol. Chronic inflammation degrades collagen. Essential fatty acid intake affects the skin's capacity to build its own lipid barrier, which is precisely what has declined.
Where supplementation is appropriate she typically looks at a small number of things. DHA and EPA omegas for inflammatory modulation and barrier support. Practitioner-grade collagen, where form and bioavailability matter far more than the number on the label. Magnesium, for sleep and stress regulation.
Everything is individualised following consultation, and anything requiring medical investigation goes to your GP.
This comes up constantly, usually in a form more confident than the research supports, so it is worth setting out properly.
The mechanism is real and well described. Oestrogen is metabolised in the liver and packaged for excretion into the gut. Certain gut bacteria produce an enzyme called beta-glucuronidase, which can unpackage some of that oestrogen, allowing it to be reabsorbed back into circulation rather than excreted. The collection of gut organisms capable of this is referred to as the estrobolome.
That is a genuine, documented pathway by which gut bacteria influence circulating oestrogen exposure.
Some large studies support a menopausal shift. A cross-sectional analysis within a large and diverse population cohort, published in mSystems in 2022 using shotgun metagenomic sequencing, found significant associations between menopausal status and the gut microbiome, including reduced diversity, altered overall composition, and depletion of the beta-glucuronidase estrobolome marker in postmenopausal compared with premenopausal women. Notably, the postmenopausal microbiome more closely resembled that of men.
And a recent meta-analysis did not find what the hypothesis predicts. A 2026 systematic review and meta-analysis published in Frontiers in Endocrinology compared gut microbiome findings between women with low oestrogen and women with normal oestrogen, and found no significant differences in diversity, in the relative abundance of the major bacterial groups, or in their ratio. The findings held across subgroup analyses and across sequencing methods, and the authors noted explicitly that this contrasts with the estrobolome hypothesis.
So where does that leave us.
The mechanism is biologically plausible and reasonably well characterised. Some substantial cohort data supports a menopause-associated shift. A recent aggregate analysis does not confirm the differences the theory predicts.
That is a genuinely unsettled field, and we would rather tell you so than sell you a protocol on the strength of the confident version you will read elsewhere.
What we think is reasonable: if you have digestive symptoms, if your general health suggests something worth investigating, or if you want to work on inflammation, sleep and nutrition during this transition, that is a sensible thing to do with Alida and it will likely benefit you in ways beyond your skin.
What we will not tell you: that fixing your gut will manage your menopause, replace hormonal management, or resolve your skin. There is no good evidence for any of that.
We would also say plainly that bone density and muscle mass matter more than your skin does at this stage, and that resistance training and adequate protein are worth more than anything in a bottle. That conversation belongs with your doctor, and we will encourage you to have it.
Alida offers manual lymphatic drainage, and patients at this stage often find it genuinely valuable. We want to be accurate about what for.
Where the evidence is strongest is in true lymphoedema, particularly following breast cancer surgery, which is where most of the research sits. Even there the picture is more contested than commonly presented. Systematic reviews describe it as potentially effective but not well established, and at least one substantial multicentre randomised trial found it added no further volume reduction when combined with standard decongestive therapy.
For facial and cosmetic applications, the evidence base is thin. There is very little high-quality trial data on manual lymphatic drainage for facial puffiness or skin appearance, and we are not going to pretend otherwise.
What is reasonably supported is the effect on stress physiology. A single-blind randomised controlled trial in healthy subjects measured salivary cortisol before and after treatment and found a significant reduction afterwards. Given how central sleep disruption and stress load are to this stage of life, and given that cortisol influences both collagen production and inflammation, that is not a trivial finding.
So we position it honestly. It is a calming, gentle, well-tolerated treatment with a documented effect on stress markers, it suits skin that will not currently tolerate anything active, and it supports recovery after other treatments. Patients frequently describe reduced facial puffiness and find it valuable.
What we will not claim is that it detoxifies, that it produces lasting change in facial appearance, or that it has an evidence base it does not have.
Alida also offers remedial face release and TMJ release, which are separate treatments and useful for anyone holding tension through the jaw, which is common when sleep is disrupted.
Infrared sauna, cold plunge and private shower in a private, solo-use space.
Two honest notes for this stage. Heat stimulates pigment production independently of UV, so if melasma is part of your picture, sauna use needs discussing rather than assuming. And if you are experiencing vasomotor symptoms, adding deliberate heat may not be what your body wants.
Some women find it genuinely restorative. Others should not. We will talk it through rather than adding it by default.
Weeks 1 to 8. Assessment. Barrier rebuilt first, always. Cleanser corrected. Home care simplified then rebuilt in stages. Gentle in-clinic work only. Retinoid introduced slowly toward the end of this phase.
Weeks 8 to 24. Collagen stimulation begins. Skin needling with boosters, spaced appropriately for slower healing. Peels progressing as tolerance builds. Pigment and vascular work where indicated.
Ongoing. Maintenance, seasonally adjusted, indefinitely. This is a stage to be managed rather than corrected once.
A note on measurement. Collagen remodelling continues for months after treatment and change is gradual. We photograph under standardised conditions, because comparing your face today to your memory of it three years ago is not a measurement and it is rarely kind.
We will not quote before we have seen your skin.
At consultation you will get a clear, itemised plan covering the corrective phase, roughly how long it runs, and what maintenance looks like afterwards. No pressure to commit on the day.
Think of this as ongoing rather than one-off. The corrective phase has an end point. The maintenance does not, because the hormonal driver does not reverse.
If budget is a constraint, tell us. At this stage the highest-value spend is almost always barrier repair, sunscreen and a retinoid, and those are not the most expensive things we sell.
Cosmetic and dermal treatments do not attract a Medicare rebate. Some private health extras cover naturopathy consultations.
To your GP if you are under forty-five and experiencing these changes, if symptoms are affecting your quality of life more broadly, if you want to discuss hormone therapy, if there is a thyroid or other systemic question, or if your skin has not responded to appropriate treatment.
To a GP or dermatologist for a skin check if you have not had one, particularly given decades of Australian sun now surfacing.
We are a medical-dermal clinic, not a prescribing practice for menopause, and part of good practice is knowing where our scope ends.
The rate of change around menopause is several times ordinary chronological ageing, and the drivers are specific rather than vague. There is a great deal that can be done, and this is the point at which intervention is worth the most.
Hormone levels in perimenopause fluctuate dramatically, sometimes within a single day. Current guidance is that diagnosis in women over forty-five is clinical rather than based on blood tests, precisely because single measurements are unreliable.
Normal bloods do not mean nothing is happening.
The most common and most expensive mistake. Menopausal skin needs more support and tolerates less intervention. Aggressive treatment on a thin, reactive, slow-healing skin produces inflammation, and inflammation degrades the collagen you are trying to build.
The evidence for oral collagen is more mixed than the marketing suggests, form and bioavailability matter enormously, and nothing in a sachet outperforms sunscreen and a retinoid. We use practitioner formulations where appropriate, as one supporting element rather than the strategy.
It is not. Skin retains the capacity to respond at every age. What changes is the pace and the tolerance, not the possibility, and women who start at sixty still see meaningful change.
They do not. Some women sail through with minimal change. Others get four things at once. Genetics, sun history, skin type and general health all contribute, and the plan should reflect what you actually have rather than a standard menopause protocol.
Ideally in perimenopause rather than after. The collagen loss is steepest in the first five years after menopause, so intervention beforehand is protecting a larger base.
That said, starting later is genuinely worthwhile and we treat women at every stage with good results.
Because the skin it was formulated for no longer exists. Lower sebum, less lipid, a thinner barrier and reduced water-holding capacity mean a routine that suited you at thirty-eight can be actively stripping at forty-eight.
This is the most common thing we correct and it is usually the fastest improvement anyone sees.
Very easily, and it is one of the more frustrating combinations. Falling oestrogen reduces sebum output while shifting the androgen ratio that drives acne. The two are not contradictory and they need treating together, which is not how either is usually approached.
That is a question for your GP or a menopause specialist, and skin is one consideration among many in that decision. Oestrogen has documented effects on skin physiology, and we will not offer you a view beyond that.
Yes, with adjusted protocols and longer intervals. Healing is slower and the barrier needs to be robust first. We treat this stage constantly and get good results, we just do it differently.
Only if you treat your neck. It is thinner, it has fewer sebaceous glands, it shows this stage earlier, and it is almost universally neglected. Whatever you use on your face should continue downward.
Overlapping but not identical. Everything on our skin ageing page applies. This page covers what is specific to the hormonal transition, which is a compressed and distinct phase rather than simply more of the same.
Every plan at Plump begins with a full consultation. We assess your skin properly, work out which of these changes are actually present, explain what is happening and why, and build a plan that respects both what your skin needs and what it can currently tolerate.
You will not be told this is just age.
There is no cost and no obligation.
Book online, or call or text us on 0478 844 048
Plump Aesthetic Clinic
525 Chapel Street, South Yarra
We see patients from South Yarra, Prahran, Windsor, Toorak, Armadale, Richmond, Malvern, St Kilda, and across inner Melbourne.
Reviewed by the clinical team at Plump Aesthetic Clinic. Caitlin King, Registered Nurse, Founder and Clinical Director, ten years in cosmetic medicine. Belinda, Senior Dermal Clinician, approximately ten years of industry experience.
We treat skin, not trends. Where we make a claim about what a treatment does, we want it to be traceable to something better than marketing.
This is an area where the physiology is well described and the treatment evidence is thinner than it should be. Despite skin being among the organs most affected by menopause, there are currently no therapies approved specifically for menopause-related skin change, which tells you something about how little attention this has received.
We have referenced clinical guidance on menopause itself alongside the dermatological literature, and where we are working from mechanism rather than trial data, we will say so.
Important information: All treatments described on this page require an individual consultation with a qualified practitioner to determine suitability. Results vary between individuals and depend on skin type, hormonal status, sun history, general health and the treatment plan followed. No result is guaranteed. All treatments carry risks and potential side effects, which will be explained to you in full before you proceed. This information is general in nature and is not a substitute for individual medical advice. We do not diagnose or manage menopause and we do not prescribe hormone therapy. If you are experiencing symptoms affecting your health or quality of life, please see your GP or a menopause specialist.
